Quality of life in patients with various Barrett's esophagus associated health states

Health and Quality of Life Outcomes

Volumn 4, Issue , 2006, Pages

  Hur, Chin ^a   Wittenberg, Eve ^a   Nishioka, Norman S ^a   Gazelle, G Scott ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; ESOPHAGOSCOPY; ESOPHAGUS RESECTION; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MALE; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PHOTODYNAMIC THERAPY; PILOT STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; URBAN AREA; VALIDITY; DECISION MAKING; DYSPHAGIA; ESOPHAGUS TUMOR; HOSPITAL; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTOCHEMOTHERAPY; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; REPRODUCIBILITY; SICKNESS IMPACT PROFILE;

AGED; BARRETT ESOPHAGUS; DECISION MAKING; DEGLUTITION DISORDERS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; HOSPITALS, URBAN; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PILOT PROJECTS; QUALITY OF LIFE; QUESTIONNAIRES; RECURRENCE; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE;

EID: 33748638023     PISSN: 14777525     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-4-45     Document Type: Article

References (33)

1. Lagergren J, Bergstrom R, Lindgren A, Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999, 340(11):825-831.
2. Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997, 112(5):1448-1456.
3. Devesa SS, Blot WJ, Fraumeni JFJ: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998, 83(10):2049-2053.
4. Weston AP, Sharma P, Topalovski M, Richards R, Cherian R, Dixon A: Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol 2000, 95(8):1888-1893.
5. Edwards MJ, Gable DR, Lentsch AB, Richardson JD: The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 1996, 223(5):585-9; discussion 589-91.
6. Heitmiller RF, Redmond M, Hamilton SR: Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996, 224(1):66-71.
7. Rice TW, Falk GW, Achkar E, Petras RE: Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993, 88(11):1832-1836.
8. Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC: Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg 1992, 54(2):199-204.
9. Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR: Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994, 108(5):813-21; discussion 821-2.
10. Falk GW, Rice TW, Goldblum JR, Richter JE: Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 1999, 49(2):170-176.
11. Stein HJ: Esophageal cancer: screening and surveillance. Results of a consensus conference held at the VIth World Congress of the International Society for Diseases of the Esophagus. Dis Esophagus 1996, 9:s3-19.
12. Begg CB, Cramer LD, Hoskins WJ, Brennan MF: Impact of hospital volume on operative mortality for major cancer surgery. Jama 1998, 280(20):1747-1751.
13. Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O'Connell S, Seidel UJ, Sonnenberg A: Long-term nonsurgical management of barrett's esophagus with high-grade dysplasia. Gastroenterology 2001, 120(7):1607-1619.
14. Overholt BF, Panjehpour M, Haydek JM: Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 1999, 49(1):1-7.
15. Hur C, Nishioka NS, Gazelle GS: Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig Dis Sci 2003, 48(7):1273-1283.
16. Ross PL, Littenberg B, Fearn P, Scardino PT, Karakiewicz PI, Kattan MW: Paper standard gamble: a paper-based measure of standard gamble utility for current health. Int J Technol Assess Health Care 2003, 19(1):135-147.
17. Hur C, Wittenberg E, Nishioka NS, Gazelle GS: Patient preferences for the management of high-grade dysplasia in Barrett's esophagus. Dig Dis Sci 2005, 50(1):116-125.
18. Hur C, Wittenberg E, Nishioka NS, Gazelle GS: Patient Preferences for the Management of HGD in Barrett's Esophagus. Gastroenterology 2004, 126(4 Suppl 2):A-113 [Abstract].
19. Torrance GW: Measurement of health state utilities for economic appraisal: A review. J Health Econ 1986, 5:1-30.
20. Littenberg B, Partilo S, Licata A, Kattan MW: Paper Standard Gamble: the reliability of a paper questionnaire to assess utility. Med Decis Making 2003, 23(6):480-488.
21. Torrance GW, Boyle MH, Horwood SP: Application of multi-attribute utility theory to measure social preferences for health states. Oper Res 1982, 30:1043-1069.
22. Furlong W FDHTGWBRHJ: Guide to Design and Development of Health-State Unitility Instrumentation. In Centre for Health Economics and Policy Analysis Working Paper Series #90-9 Hamilton, Ontario, Canada: McMaster University; 1990.
23. Gerson LB, Ullah N, Hastie T, Triadafilopoulos G, Goldstein M: Patient-derived health state utilities for gastroesophageal reflux disease. Am J Gastroenterol 2005, 100(3):524-533.
24. Fisher D, Jeffreys A, Bosworth H, Wang J, Lipscomb J, Provenzale D: Quality of life in patients with Barrett's esophagus undergoing surveillance. Am J Gastroenterol 2002, 97(9):2193-2200.
25. Provenzale D, Schmitt C, Wong JB: Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999, 94(8):2043-2053.
26. Fryback DG, Dasbach EJ, Klein R, Klein BE, Dorn N, Peterson K, Martin PA: The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making 1993, 13(2):89-102.
27. Ferguson MK, Naunheim KS: Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg 1997, 114(5):824-829.
28. Headrick JR, Nichols FC, Miller DL, Allen MS, Trastek VF, Deschamps C, Schleck CD, Thompson AM, Pairolero PC: High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg 2002, 73(6):1697-702; discussion 1702-3.
29. Bueno R, Swanson SJ, Jaklitsch MT, Lukanich JM, Mentzer SJ, Sugarbaker DJ: Combined antegrade and retrograde dilation: a new endoscopic technique in the management of complex esophageal obstruction. Gastrointestinal Endoscopy 2001, 54(3):368-372.
30. Hur C, Nishioka NS, Gazelle GS: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst 2004, 96(4):316-325.
31. Barham CP, Jones RL, Biddlestone LR, Hardwick RH, Shepherd NA, Barr H: Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation. Gut 1997, 41(3):281-284.
32. Bonavina L, Ceriani C, Carazzone A, Segalin A, Ferrero S, Peracchia A: Endoscopic laser ablation of nondysplastic Barrett's epithelium: is it worthwhile? J Gastrointest Surg 1999, 3(2):194-199.
33. Sampliner RE: Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002, 97(8):1888-1895.